These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12559689)

  • 21. The carcinogenic potential of ethylene.
    Hopkins J
    Food Chem Toxicol; 1994 Feb; 32(2):191-3. PubMed ID: 8132179
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular dosimetry of endogenous and ethylene oxide-induced N7-(2-hydroxyethyl) guanine formation in tissues of rodents.
    Wu KY; Ranasinghe A; Upton PB; Walker VE; Swenberg JA
    Carcinogenesis; 1999 Sep; 20(9):1787-92. PubMed ID: 10469625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health- and vegetative-based effect screening values for ethylene.
    Erraguntla NK; Grant RL
    Chem Biol Interact; 2015 Nov; 241():87-93. PubMed ID: 25727267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
    Preston RJ
    Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of concentrations of styrene-7,8-oxide in rats and humans resulting from exposure to styrene or styrene-7,8-oxide and potential genotoxicity.
    Filser JG; Gelbke HP
    Toxicol Lett; 2016 Apr; 247():11-28. PubMed ID: 26851640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species and strain differences in the hepatic cytochrome P450-mediated biotransformation of 1,4-dichlorobenzene.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Van Bladeren PJ
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):1-9. PubMed ID: 9221818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhalation toxicokinetics of p-dichlorobenzene and daily absorption and internal accumulation in chronic low-level exposure to humans.
    Yoshida T; Andoh K; Kosaka H; Kumagai S; Matsunaga I; Akasaka S; Nakamura S; Oda H; Fukuhara M
    Arch Toxicol; 2002 Jun; 76(5-6):306-15. PubMed ID: 12107648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA adducts of styrene-7,8-oxide in target and non-target organs for tumor induction in rat and mouse after repeated inhalation exposure to styrene.
    Otteneder M; Lutz U; Lutz WK
    Mutat Res; 2002 Mar; 500(1-2):111-6. PubMed ID: 11890940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of inclusion of kinetic information in the extrapolation of high-to-low concentrations for human limit setting.
    Geraets L; Zeilmaker MJ; Bos PMJ
    Toxicol Lett; 2018 Jan; 282():81-92. PubMed ID: 29030269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment.
    Proctor DM; Gatto NM; Hong SJ; Allamneni KP
    Toxicol Sci; 2007 Aug; 98(2):313-26. PubMed ID: 17426108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the health effects of chemicals in humans: I. QSAR estimation of the maximum recommended therapeutic dose (MRTD) and no effect level (NOEL) of organic chemicals based on clinical trial data.
    Matthews EJ; Kruhlak NL; Benz RD; Contrera JF
    Curr Drug Discov Technol; 2004 Jan; 1(1):61-76. PubMed ID: 16472220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
    McGregor D
    Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 97. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide).
    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
    IARC Monogr Eval Carcinog Risks Hum; 2008; 97():3-471. PubMed ID: 20232717
    [No Abstract]   [Full Text] [Related]  

  • 34. Tissue dosimetry, physiologically-based pharmacokinetic modeling, and cancer risk assessment.
    Andersen ME
    Cell Biol Toxicol; 1989 Dec; 5(4):405-15. PubMed ID: 2627676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjustment factors for toluene, styrene and methyl chloride by population modeling of toxicokinetic variability.
    Mörk AK; Jonsson F; Johanson G
    Regul Toxicol Pharmacol; 2014 Jun; 69(1):78-90. PubMed ID: 24613484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty/safety factors.
    Gaylor DW; Kodell RL; Chen JJ; Krewski D
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):151-7. PubMed ID: 10341145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic effects and biotoxicity monitoring of occupational styrene exposure.
    Rueff J; Teixeira JP; Santos LS; Gaspar JF
    Clin Chim Acta; 2009 Jan; 399(1-2):8-23. PubMed ID: 18845133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA adducts: effects of low exposure to ethylene oxide, vinyl chloride and butadiene.
    Swenberg JA; Ham A; Koc H; Morinello E; Ranasinghe A; Tretyakova N; Upton PB; Wu K
    Mutat Res; 2000 Jan; 464(1):77-86. PubMed ID: 10633179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.